SINGAPORE - Oncologists say they often use drugs "off label" to treat cancers, especially after conventional treatments fail.
Off label refers to the use of an otherwise approved drug in a setting for which it has not received regulatory approval. This could be because the drug is still new and clinical trials for its use for certain conditions are ongoing. Or it could be because the drug company does not think it is worth the expense and effort to get it approved.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you